Targeting drug delivery within the suprachoroidal space

Huang, 2018, Overcoming ocular drug delivery barriers through the use of physical forces, Adv. Drug Deliv. Rev., 126, 96, 10.1016/j.addr.2017.09.008 Kaji, 2018, Drug delivery devices for retinal diseases, Adv. Drug Deliv. Rev., 128, 148, 10.1016/j.addr.2017.07.002 Peynshaert, 2018, In vitro and ex vivo models to study drug delivery barriers in the posterior segment of the eye, Adv. Drug Deliv. Rev., 126, 44, 10.1016/j.addr.2017.09.007 Chiang, 2018, The suprachoroidal space as a route of administration to the posterior segment of the eye, Adv. Drug Deliv. Rev., 126, 58, 10.1016/j.addr.2018.03.001 Thakur Singh, 2017, Minimally invasive microneedles for ocular drug delivery, Expert Opin. Drug Deliv., 14, 525, 10.1080/17425247.2016.1218460 Barar, 2016, Advanced drug delivery and targeting technologies for the ocular diseases, Bioimpacts, 6, 49, 10.15171/bi.2016.07 Kim, 2014, Ocular delivery of macromolecules, J. Control. Release, 190, 172, 10.1016/j.jconrel.2014.06.043 Moisseiev, 2016, The suprachoroidal space: From potential space to a space with potential, Clin. Ophthalmol., 10, 173, 10.2147/OPTH.S89784 Rai Udo, 2015, The suprachoroidal pathway: A new drug delivery route to the back of the eye, Drug Discov. Today, 20, 491, 10.1016/j.drudis.2014.10.010 Christian, J. et al. iScience Surgical Corp. Composite ophthalmic microcannula. US7207980B2. Wellik, 2015, A review of the istent((r)) trabecular micro-bypass stent: Safety and efficacy, Clin. Ophthalmol., 9, 677, 10.2147/OPTH.S57217 Malvankar-Mehta, 2015, Istent as a solo procedure for glaucoma patients: a systematic review and meta-analysis, PLoS ONE, 10, 10.1371/journal.pone.0128146 Hoh, 2014, Two-year clinical experience with the cypass micro-stent: safety and surgical outcomes of a novel supraciliary micro-stent, Klin. Monbl. Augenheilkd., 231, 377, 10.1055/s-0034-1368214 Patel, 2016, Targeted drug delivery within the eye through the suprachoroidal space, J. Ocul. Pharmacol. Ther., 32, 640, 10.1089/jop.2016.0158 Patel, 2012, Targeted administration into the suprachoroidal space using a microneedle for drug delivery to the posterior segment of the eye, Invest. Ophthalmol. Vis. Sci., 53, 4433, 10.1167/iovs.12-9872 Patel, 2011, Suprachoroidal drug delivery to the back of the eye using hollow microneedles, Pharm. Res., 28, 166, 10.1007/s11095-010-0271-y Gilger, 2013, Treatment of acute posterior uveitis in a porcine model by injection of triamcinolone acetonide into the suprachoroidal space using microneedles, Invest. Ophthalmol. Vis. Sci., 54, 2483, 10.1167/iovs.13-11747 Jung, 2018, Ocular drug delivery targeted by iontophoresis in the suprachoroidal space using a microneedle, J. Control. Release, 277, 14, 10.1016/j.jconrel.2018.03.001 Jung, 2018, Targeted drug delivery in the suprachoroidal space by swollen hydrogel pushing, Invest. Ophthalmol. Vis. Sci., 59, 2069, 10.1167/iovs.17-23758 Kim, 2015, Formulation to target delivery to the ciliary body and choroid via the suprachoroidal space of the eye using microneedles, Eur. J. Pharm. Biopharm., 95, 398, 10.1016/j.ejpb.2015.05.020 Kim, 2014, Particle-stabilized emulsion droplets for gravity-mediated targeting in the posterior segment of the eye, Adv. Healthc. Mater., 3, 1272, 10.1002/adhm.201300696 Kim, 2014, Targeted delivery of antiglaucoma drugs to the supraciliary space using microneedles, Invest. Ophthalmol. Vis. Sci., 55, 7387, 10.1167/iovs.14-14651 Goldstein, 2016, Suprachoroidal corticosteroid administration: a novel route for local treatment of noninfectious uveitis, Transl. Vis. Sci. Technol., 5, 14, 10.1167/tvst.5.6.14 Suprachoroidal injection of CLS-TA in subjects with macular edema associated with non-infectious uveitis (peachtree). https://clinicaltrials.gov/ct2/show/NCT02595398 [accessed February 19, 2019]. Suprachoroidal injection of CLS-TA in subjects non-infectious uveitis (azalea). https://clinicaltrials.gov/ct2/show/NCT03097315 [accessed February 19, 2019]. Suprachoroidal injection of CLS-TA alone or with aflibercept in subjects with diabetic macular edema (hulk). https://clinicaltrials.gov/ct2/show/NCT02949024 [accessed February 19, 2019]. Patel, 2006, Suprachoroidal silicone oil: recognition and possible mechanisms, Eye, 20, 854, 10.1038/sj.eye.6702029 Bressler, 2011, Panretinal photocoagulation for proliferative diabetic retinopathy, N. Engl. J. Med., 365, 1520, 10.1056/NEJMct0908432 Chappelow, 2012, Panretinal photocoagulation for proliferative diabetic retinopathy: Pattern scan laser versus argon laser, Am. J. Ophthalmol., 153, 137, 10.1016/j.ajo.2011.05.035 Holz, 2014, Recent developments in the treatment of age-related macular degeneration, J. Clin. Invest., 124, 1430, 10.1172/JCI71029 Rowe-Rendleman, 2014, Drug and gene delivery to the back of the eye: From bench to bedside, Invest. Ophthalmol. Vis. Sci., 55, 2714, 10.1167/iovs.13-13707 Syed, 2012, Wet AMD market, Nat. Rev. Drug Discov., 11, 827, 10.1038/nrd3790 Ghate, 2008, Barriers to glaucoma drug delivery, J. Glaucoma, 17, 147, 10.1097/IJG.0b013e31814b990d Ethier, 2004, Ocular biomechanics and biotransport, Annu. Rev. Biomed. Eng., 6, 249, 10.1146/annurev.bioeng.6.040803.140055 Falavarjani, 2013, Adverse events and complications associated with intravitreal injection of anti-vegf agents: a review of literature, Eye, 27, 787, 10.1038/eye.2013.107 Del Amo, 2008, Current and future ophthalmic drug delivery systems. A shift to the posterior segment, Drug Discov. Today, 13, 135, 10.1016/j.drudis.2007.11.002 Prausnitz, 2008, Transdermal drug delivery, Nat. Biotechnol., 26, 1261, 10.1038/nbt.1504 Gungor, 2010, Trans-scleral iontophoretic delivery of low molecular weight therapeutics, J. Control. Release, 147, 225, 10.1016/j.jconrel.2010.07.107 Eljarrat-Binstock, 2006, Iontophoresis: a non-invasive ocular drug delivery, J. Control. Release, 110, 479, 10.1016/j.jconrel.2005.09.049 Calo, 2015, Biomedical applications of hydrogels: a review of patents and commercial products, Eur. Polym. J., 65, 252, 10.1016/j.eurpolymj.2014.11.024 Hoare, 2008, Hydrogels in drug delivery: progress and challenges, Polymer, 49, 1993, 10.1016/j.polymer.2008.01.027 Hoffman, 2012, Hydrogels for biomedical applications, Adv. Drug Deliv. Rev., 64, 18, 10.1016/j.addr.2012.09.010 Burdick, 2011, Hyaluronic acid hydrogels for biomedical applications, Adv. Mater., 23, H41, 10.1002/adma.201003963 Fraser, 1997, Hyaluronan: Its nature, distribution, functions and turnover, J. Intern. Med., 242, 27, 10.1046/j.1365-2796.1997.00170.x Strom, 2015, Preparation and physical properties of hyaluronic acid-based cryogels, J. Appl. Polym. Sci., 132, 42194, 10.1002/app.42194 Kleinberg, 2011, Vitreous substitutes: a comprehensive review, Surv. Ophthalmol., 56, 300, 10.1016/j.survophthal.2010.09.001 Weinberger, 1998, Long-term follow-up of perfluorocarbon liquid in the anterior chamber, Retina, 18, 233, 10.1097/00006982-199803000-00007 Liu, 2006, Encapsulated ultrasound microbubbles: therapeutic application in drug/gene delivery, J. Control. Release, 114, 89, 10.1016/j.jconrel.2006.05.018 Pickering, 1907, Cxcvi.—emulsions, J. Chem. Soc. Trans., 91, 2001, 10.1039/CT9079102001 Aveyard, 2003, Emulsions stabilised solely by colloidal particles, Adv. Colloid Interface Sci., 100–102, 503, 10.1016/S0001-8686(02)00069-6 Csukas, 1992, Prostaglandin e2 binding site distribution and subtype classification in the rabbit iris-ciliary body, Prostaglandins, 44, 199, 10.1016/0090-6980(92)90013-J Toris, 2008, Update on the mechanism of action of topical prostaglandins for intraocular pressure reduction, Surv. Ophthalmol., 53, S107, 10.1016/j.survophthal.2008.08.010 Urtti, 2006, Challenges and obstacles of ocular pharmacokinetics and drug delivery, Adv. Drug Deliv. Rev, 58, 1131, 10.1016/j.addr.2006.07.027 Kaur, 2004, Vesicular systems in ocular drug delivery: an overview, Int. J. Pharm., 269, 1, 10.1016/j.ijpharm.2003.09.016 Bhatt, 2005, Prospective survey of adverse reactions to topical antiglaucoma medications in a hospital population, Eye, 19, 392, 10.1038/sj.eye.6701515 Reardon, 2011, Objective assessment of compliance and persistence among patients treated for glaucoma and ocular hypertension: a systematic review, Patient Pref. Adher., 5, 441, 10.2147/PPA.S23780 Chiang, 2016, Sustained reduction of intraocular pressure by supraciliary delivery of brimonidine-loaded poly(lactic acid) microspheres for the treatment of glaucoma, J. Control. Release, 228, 48, 10.1016/j.jconrel.2016.02.041 Hovakimyan, 2015, Development of an experimental drug eluting suprachoroidal microstent as glaucoma drainage device, Transl. Vis. Sci. Technol., 4, 14, 10.1167/tvst.4.3.14 Chen, 2015, Safety and pharmacodynamics of suprachoroidal injection of triamcinolone acetonide as a controlled ocular drug release model, J. Control. Release, 203, 109, 10.1016/j.jconrel.2015.02.021